Some people make medicine from plants called cannabis, which have stuff that makes you feel high. In California, there are rules about how much of this stuff is in the plant and how it should be tested. Some places didn't follow the rules and lied about how strong the plants were to sell them for more money. Now, the people who make the rules say only 13 places can test the plants correctly. This means that not all the medicine from cannabis plants is good or safe. Read from source...

- The title is misleading and sensationalized. It implies that there are only a few labs that qualify as state standards, while the reality is more nuanced and depends on the product category being tested.
- The article does not provide enough context or background information about the new testing requirements and their rationale. It assumes that the reader already knows why standardized cannabinoid testing methods are important and necessary for protecting consumers and ensuring product quality.
- The article uses vague and ambiguous terms like "scams" and "pumping up the amount of THC" without providing any evidence or examples to support these claims. It also does not address the possibility of human error, measurement variability, or other factors that could affect the accuracy and consistency of cannabinoid testing results.
- The article focuses on the negative consequences of the new testing requirements for the industry, such as reduced competition, market fragmentation, and higher costs for producers and consumers. It does not mention any potential benefits or advantages of having standardized and transparent testing methods, such as increased consumer confidence, product safety, and quality assurance.
- The article relies on sources that may have a vested interest in promoting their own labs or products, such as executives from Infinite Chemical Analysis Labs and Anresco. It does not present any alternative perspectives or independent verification of the claims made by these sources.